Therapy with vitamin D metabolits of structural and functional changes in bone tissue of working postmenopausal women with ostearcopenia

The prevalence of osteoporosis and vitamin D deficiency in postmenopausal women working under harmful labour conditions has been examined. Reduced bone mineral density was revealed in 85% of the persons under observation, the incidence of OP was 35%, sarcopenia (SP) - 35%. Vitamin D deficiency was f...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Ignatiev (Author), M. Turchin (Author), T. Ermolenko (Author), O. Panyuta (Author)
Format: Book
Published: Kazimierz Wielki University, 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_06ebe3b239944e9f86d62edf6048e6a2
042 |a dc 
100 1 0 |a O. Ignatiev  |e author 
700 1 0 |a M. Turchin  |e author 
700 1 0 |a T. Ermolenko  |e author 
700 1 0 |a O. Panyuta  |e author 
245 0 0 |a Therapy with vitamin D metabolits of structural and functional changes in bone tissue of working postmenopausal women with ostearcopenia 
260 |b Kazimierz Wielki University,   |c 2022-05-01T00:00:00Z. 
500 |a 10.12775/JEHS.2022.12.05.026 
500 |a 2391-8306 
520 |a The prevalence of osteoporosis and vitamin D deficiency in postmenopausal women working under harmful labour conditions has been examined. Reduced bone mineral density was revealed in 85% of the persons under observation, the incidence of OP was 35%, sarcopenia (SP) - 35%. Vitamin D deficiency was found in 91.3% of the workers, at the same time severe VD deficiency was observed in 32.9%, VD deficiency - in 7.5%, and the optimal level of vitamin D was observed in 1.2% of cases. 79 PM women with OP aged 50 - 60 y. o. (mean age - (55.7 ± 0.9) years), working at harmful  conditions of the working environment with an average length of service 26.14 ± 0.91 years have been examined. Clinical group A (n = 30) received cholecalciferol at a dose of 2000 IU (4 drops) per day and alfacalcidol 1 μg (1 capsule) once a day for a year. This resulted in a positive effect on the level of 25(OH)D. The complex appointment of cholecalciferol and alfacalcidol reduced the level of PTH and confirmed the role of VD deficiency in the progress of secondary hyperparathyroidism. The data obtained revealed a slowing of the effect of VD on osteoclastogenesis. Decrease of bone resorption marker CTx in the women under examination confirmed the latter. 
546 |a EN 
546 |a ES 
546 |a PL 
546 |a RU 
546 |a UK 
690 |a postmenopausal woman 
690 |a harmful labour conditions 
690 |a bone mineral density 
690 |a vitamin D metabolit 
690 |a Education 
690 |a L 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Medicine 
690 |a R 
655 7 |a article  |2 local 
786 0 |n Journal of Education, Health and Sport, Vol 12, Iss 5 (2022) 
787 0 |n https://apcz.umk.pl/JEHS/article/view/39014 
787 0 |n https://doaj.org/toc/2391-8306 
856 4 1 |u https://doaj.org/article/06ebe3b239944e9f86d62edf6048e6a2  |z Connect to this object online.